Cellebrite Presents Advanced Access as a Service at Techno Security & Digital Forensics Conference

Introducing Cellebrite’s advanced access capabilities as a cloud-based service aims to enable a broader base of law enforcement agencies to take advantage of the latest technologies

Petah Tikva, Israel, and Tysons Corner, Virginia, May 09, 2022 (Globe Newswire) – Cellebrite DI Ltd. (NASDAQ: CLBT), the leading global provider of digital intelligence (DI) solutions to the public and private sectors, today announced the upcoming release of SaaS-based Cellebrite Premium. Cellebrite Premium is an industry-leading advanced access solution that provides unlocking and extraction capabilities for most of the leading iOS and Android devices. The new offering, part of Cellebrite’s market-leading DI suite of solutions, will be unveiled at the upcoming Techno Security & Digital Forensics conference to be held in Myrtle Beach, South Carolina, May 9-12, 2022.

The solution aims to enable law enforcement agencies to take advantage of flexible licensing options and reduce ongoing hardware and maintenance costs. In addition, the SaaS-based version of Premium aims to provide agencies with instant access to the latest features and enable more law enforcement agencies to decentralize access to devices and data collection to speed up digital investigations and reduce case backlogs.

Ronin Armon, Head of Products and Technology, Cellebrite, said: “Law enforcement agencies of all sizes should have access to solutions that can help them address ever-increasing digital evidence challenges. Our goal is to meet the needs of our customers as the volume, diversity, and complexity of digital evidence continues to grow.” Using our most advanced capabilities is our latest innovation to achieve this goal. We look forward to continuing to work with our customers to empower them, protect and save lives, accelerate justice, and protect privacy in communities around the world.”

For more information about Cellebrite Premium, visit https://cellebrite.com/en/premium/

About Silbright
Celebrate https://investors.cellebrite.com/or on Twitter at Tweet embed.

Cautionary note regarding forward-looking statements

This document contains forward-looking statements within the meaning of the “safe harbor” provisions of the US Securities Litigation Reform Act of 1995. Forward-looking statements may be identified using words such as “expect”, “intend”, “objective”, “objective”. “expect”, “will”, “appear”, “likely”, “anticipate”, “could”, “probable”, “believe”, “anticipate”, “should” and “could” and “communicate,” “anticipate,” “estimate,” “may,” “plan,” “expect,” “future,” “intent,” and similar expressions that predict, anticipate, or indicate the future by events or trends, or through data Identifiable trends that are not statements about historical facts These forward-looking statements include estimates of the financial statements Forward-looking statements regarding Cellebrite’s earnings, earnings, performance, strategy, prospects and other business are based on current expectations that involve risks and uncertainties Various factors may cause results or results to differ These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological progress and evolving industry standards; Cellebrite’s greater reliance on law enforcement and government agency acceptance of its solutions; errors, failures, deficiencies, or errors; or Perceived in Cellebrite’s DI solutions; failure Cellebrite in maintaining the productivity of sales and marketing personnel, including in relation to recruitment, onboarding, and retention; doubts regarding the impact of the macroeconomic and/or global conditions, including COVID-19, and military actions in which Russia and Ukraine are involved; intense competition in all markets in which Cellebrite operates; Accidental or intentional misuse of Cellebrite solutions; political and reputational factors related to Cellebrite’s business or operations; risks related to assessing market opportunities and forecasting market growth; The ability of Cellebrite to properly control its growth; Risks related to Cellebrite’s credit and liquidity facilities; Cellebrite’s reliance on third party suppliers for certain components, products or services; Challenges associated with large transactions and long sales cycles; the risk of Cellebrite customers failing to meet their contractual or payment obligations; The risks associated with having a significant portion of Cellebrite’s business derive from government customers around the world; risks associated with Cellebrite’s intellectual property; security breaches or failures, including cyberattacks, information technology breaches, failures or disruptions; mishandling or appearance of sensitive or confidential information; The complex and changing regulatory environment related to Cellebrite processes and solutions; regulatory restrictions to which we are subject; the risks related to the various corporate governance requirements applicable to Israeli companies and the risks associated with being a foreign private issuer and an emerging growth company; market fluctuations in the share price of Cellebrite; changing tax laws and regulations; risks associated with joint ventures, partnerships and strategic initiatives; Risks Associated With Cellebrite’s Extensive International Operations; Risks related to Cellebrite’s failure to comply with anti-corruption, commercial compliance, anti-money laundering and economic sanctions laws and regulations; risks related to the adequacy of Cellebrite’s current systems, processes, policies, procedures, internal controls, and personnel for Cellebrite’s current and future operational and reporting needs; and other factors, risks, and uncertainties discussed in the “Risk Factors” section of Cellebrite’s annual report on Form 20-F filed with the SEC on March 29, 2022 and in other Cellebrite filings with the U.S. Securities and Exchange Commission (“SEC”) filings , which is available free of charge at www.sec.gov. You are cautioned not to place undue reliance on any forward-looking statement, which speaks only as of the date of this release or elsewhere. Cellebrite does not undertake to update its forward-looking statements, whether as a result of new information, future developments or otherwise, if circumstances change, except as required by securities or other applicable laws.

contact person

The media
Rene Soto
+1 212-433-4606
[email protected]

Anat Iron Helburn
Vice President of Investor Relations
+972 73394 8440
[email protected]

Leave a Comment